| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c20478 _d20478 |
||
| 001 | BD-DhNSU-20478 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064243.0 | ||
| 008 | 190403s1998 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0824798848 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS189 _b.A37 1998 |
| 100 | 1 | _aAhuja, Satinder | |
| 245 | 0 | 0 |
_aImpurities evaluation of pharmaceuticals / _cSatinder Ahuja |
| 260 |
_aNew York : _bMarcel Dekker, _cc1998. |
||
| 300 |
_aiv, 293 p. : _bill. ; _c24 cm. |
||
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aAnalysis | |
| 650 | 4 | _aContamination | |
| 942 |
_2lcc _cBK |
||